Cannabis-based medicine will soon be available in France, as the country’s health officials recently approved commercial sales of the drug for the first time in history.
A report from the Associated Press indicates that Britain’s GW Pharmaceuticals has been granted permission from the Health Ministry to begin marketing its latest drug, Sativex, a cannabinoid medicine used to treat specific symptoms of multiple sclerosis.
Read more here http://www.hightimes.com/read/france-approves-cannabis-based-medicine
